A pooled electronic consultation program to improve access to genetics specialists
Emma K. Folkerts(Broad Institute), Leland E. Hull(Harvard University), Renée C. Pelletier(Broad Institute), Eugene Wong(Massachusetts General Hospital), Kristen M. Shannon(Massachusetts General Hospital), David A. Sweetser(Massachusetts General Hospital), Daniel C. Chung(Massachusetts General Hospital), Douglas S. Micalizzi(Massachusetts General Hospital), Susan A. Goldstein(Massachusetts General Hospital), Heidi L. Rehm(Unknown)
Cited by 5
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k